Donor Gamete Services:
Sometimes, using donated eggs or sperm can help single women and couples achieve their dream of having a child. Our donor gamete program provides access to carefully screened donors who have undergone thorough medical and psychological evaluations. The samples are procured from registered ART bank. We prioritize your preferences and needs to ensure a suitable match, and our experienced team guides you through every step of the process, from donor selection to treatment.
Surrogacy Services:
Surrogacy offers a unique opportunity for single women or couples who are unable to carry a pregnancy to term to have a child genetically related to them. We provide comprehensive support and guidance, including legal and psychological counselling, surrogate screening, medical coordination, and ongoing emotional support, to ensure a smooth and successful surrogacy experience.
ADVANCED TECHNIQUES
- Microfluidics Sperm Selection
- ARTIFICIAL OOCYTE ACTIVATION
- ERA
- ASSISTED HATCHING Why Choose Assisted Hatching at CIMAR?
- Expertise and Experience: Our team of skilled embryologists and fertility specialists have extensive experience in performing Assisted Hatching procedures, using state-of-the-art equipment and techniques to ensure optimal outcomes.
- Personalized Approach: We understand that each patient’s fertility journey is unique, which is why we offer personalized treatment plans tailored to individual needs and circumstances. Our team works closely with patients to determine the most appropriate and effective treatment options.
- AH is the procedure that helps the embryo “hatch” from its shelf by creating a small crack in the zona pellucida, which can help an embryo implant in the uterine leading to higher pregnancy rate in few patients.
- PGT(Pre implantation Genetic Testing)
Welcome to our state-of-the-art Microfluidics Sperm Selection technology, a cutting-edge approach to sperm selection in assisted reproductive technology (ART). Developed to optimize fertility treatment outcomes, Microfluidics offers precise and efficient sperm selection for couples undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).
How Microfluidics Sperm Selection Works:Microfluidics technology utilizes microscale channels and chambers to separate and isolate sperm based on their physical and functional characteristics. Unlike traditional methods that rely on centrifugation or density gradient techniques, Microfluidics provides a more controlled and gentle approach to sperm selection, minimizing potential damage and preserving sperm integrity.
Artificial Oozyte Activation is a non-invasive procedure that can be used to embryo fertilization rates for undergoing ICSI. AOA can be used in cases where there has been failed or low fertilization in previous ICSI cycles.
AOA is considered a treatment add on and is not used routinely for fertility treatment. It is beneficial relatively small and specific group of patients.
The ERA test is particularly beneficial for individuals or couples who have experienced recurrent implantation failure during IVF cycles or have had difficulty achieving pregnancy despite transferring high-quality embryos. By identifying the specific timing of the endometrial receptivity window, the ERA test helps fertility specialists tailor the timing of embryo transfer to maximize the chances of success.
Pre implantation Genetic Testing (PGT) is a form of genetic screening used during an in vitro fertilization (IVF) cycle to test embryos for genetic abnormalities before they are implanted into the uterus. The goal is to increase the chances of a successful pregnancy and reduce the risk of genetic disorders.
- Couples with genetic disorder
- Recurrent Pregnancy losses
- Recurrent Implantation failure
- Advanced maternal age
- Unexplained infertility
- Family H/o. Genetic disorder
- Previous child with genetic disorder
Pre implantation Genetic Testing (PGT)
Pre implantation Genetic Testing (PGT) is a form of genetic screening used during an in vitro fertilization (IVF) cycle to test embryos for genetic abnormalities before they are implanted into the uterus. The goal is to increase the chances of a successful pregnancy and reduce the risk of genetic disorders.
Who will be benefited?
- Couples with genetic disorder
- Recurrent Pregnancy losses
- Recurrent Implantation failure
- Advanced maternal age
- Unexplained infertility
- Family H/o. Genetic disorder
- Previous child with genetic disorder